Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

Background. Prognosis of therapy results of patients with the juvenile idiopatic arthritis (JIA) without systematic manifestations is the precondition of their treatment efficiency enhancement.Objective. Our aim was to establish early predictors for remission achievement in patients with JIA without...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2019-04-01
Series:Вопросы современной педиатрии
Subjects:
children
juvenile idiopatic arthritis
therapy
predictors
risk factors
genetically engineered biologic drugs
etanercept
adverse effects
Online Access:https://vsp.spr-journal.ru/jour/article/view/2023
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://vsp.spr-journal.ru/jour/article/view/2023

Similar Items